gnckКолопроктологияKoloproktologia2073-75562686-7303Russian Association of Coloproctologygnck-1843Research ArticleСтатьиСкрининг колоректального рака у работников предприятий РОСТЕХ Свердловской области. Пилотный проект.Interval colorectal cancer. Review and retrospective analysis of the regional colon cancer screening program in terms of risk factors and colonoscopy quality indicatorsДесятовЕвгений НиколаевичDesyatovEvgeny N.polikarpova-e@yandex.ru1ФГБОУ ВО Тюменский ГМУ Минздрава России (ул. Одесская, д.54, г.Тюмень, 625023, Россия) 2ГАУЗ ТО МКМЦ «Медицинский Город» (ул. Барнаульская, д.32, г.Тюмень, 625041, Россия)Россия1Tyumen State Medical University of the Ministry of Health of Russia (st. Odesskaya, 54, Tyumen, 625023, Russia) 2"Medical City" (st. Barnaulskaya, 32, Tyumen, 625041, Russia,)Russian Federation2023210320232221843Copyright © Десятов Е.Н., 20232023Десятов Е.Н.Desyatov E.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.ruproctology.com/jour/article/view/1843ЦЕЛЬ ИССЛЕДОВАНИЯ

ЦЕЛЬ ИССЛЕДОВАНИЯ: ретроспективная оценка результатов региональной программы скрининга рака толстой кишки, выполненного на базе Тюменского областного онкологического диспансера (в настоящее время МКМЦ «Медицинский Город») и лечебных учреждений г. Тюмени и юга Тюменской области в период 2016-2018 гг.

МАТЕРИАЛЫ И МЕТОДЫ

МАТЕРИАЛЫ И МЕТОДЫ: региональная программа скрининга рака толстой кишки состоит из двух этапов. На первом этапе в лечебных учреждениях г.Тюмени и юга Тюменской области пациентам возрастной категории 40-65 лет выполнен фекальный иммунохимический тест. На 2 этапе пациенты с положительным тестом кала на скрытую кровь маршрутизируются в лечебные учреждения г.Тюмени и юга Тюменской области для выполнения скрининговой колоноскопии.

Результаты

Результаты. В 2016 - 2018 гг. на первом этапе выполнен фекальный иммунохимический тест 251847 человеку. Из них с положительным фекальным иммунохимическим тестом на скрытую кровь выполнено 22249 скрининговых исследований методом колоноскопии пациентам в возрасте 40-65 лет в отделении эндоскопии Тюменского онкодиспансера и лечебных учреждениях г.Тюмени и юга Тюменской области. Колоноскопия выполнена 4396 пациентам на базе Тюменского онкодиспансера, а 17853 человека обследованы в общелечебной сети. Методом колоноскопии у 4025 (ADR=18%) человек выявлены аденомы и аденокарциномы толстой кишки. В онкологическом диспансере выявлены аденомы и аденокарциномы толстой кишки у 1264 человек, а в лечебных учреждениях г.Тюмени и юга Тюменской области у 2761 человека. Частота выявления аденом в онкологическом диспансере составила 25,5%, а в лечебных учреждениях г.Тюмени и юга Тюменской области 12,4%. Из 4396 человек выполнивших скрининговое исследование толстой кишки в МКМЦ «Медицинский Город» в 6-летний период наблюдения 2016-2021 гг. выявлены 8 человек с ПККРР, что составляет 0,2% случаев, классифицируемых как интервальный КРР. В 3 из 8 случаев интервальный КРР локализовался в правых отделах толстой кишки.

ЗАКЛЮЧЕНИЕ

ЗАКЛЮЧЕНИЕ: прогностически в 2338 случаях выполненных скрининговых колоноскопий в лечебных учреждениях г.Тюмени и юга Тюменской области аденомы и аденокарциномы не выявлены, исходя из должной 25% частоты выявления.

Retrospective evaluation of the results of the regional colon cancer screening program, performed on the basis of the Tyumen Regional Oncological Dispensary (currently "Medical City") and medical institutions in Tyumen and the south of the Tyumen region in the period 2016-2018.

MATERIALS AND METHODS

MATERIALS AND METHODS: the regional colon cancer screening program consists of two phases. At the first stage, in medical institutions of the city of Tyumen and the south of the Tyumen region, patients aged 40-65 years old underwent a fecal immunochemical test. At stage 2, patients with a positive fecal occult blood test are routed to medical institutions in the city of Tyumen and the south of the Tyumen region for screening colonoscopy.

RESULTS

RESULTS: in 2016 - 2018 at the first stage, a fecal immunochemical test was performed on 251847 people. Of these, with a positive fecal immunochemical test for occult blood, 22249 screening studies were performed by colonoscopy for patients aged 40–65 years in the endoscopy department of the Tyumen Cancer Center and medical institutions in the city of Tyumen and the south of the Tyumen region. Colonoscopy was performed in 4396 patients on the basis of the Tyumen Cancer Center, and 17853 people were examined in the general medical network. Colonoscopy revealed adenomas and adenocarcinomas of the large intestine in 4025 (ADR=18%) patients. In the oncological dispensary, adenomas and adenocarcinomas of the colon were detected in 1264 people, and in medical institutions in the city of Tyumen and the south of the Tyumen region in 2761 people. Adenoma detection rate in the oncological dispensary was 25.5%, and in medical institutions in the city of Tyumen and the south of the Tyumen region 12.4%. Out of 4396 people who performed a screening study of the colon in the "Medical City" in the 6-year follow-up period 2016-2021. Identified 8 people with PСCRC, which is 0.2% of cases classified as interval CRC. In 3 out of 8 cases, interval CRC was localized in the right colon.

CONCLUSION

CONCLUSION: prognostically, in 2338 cases of screening colonoscopies performed in medical institutions in the city of Tyumen and the south of the Tyumen region, adenomas and adenocarcinomas were not detected, based on the proper 25% detection rate.

постколоноскопический колоректальный ракфекальный иммунохимический тестинтервальный колоректальный ракскрининговая колоноскопияаденомаpost colonoscopy colorectal cancerfecal immunochemical testinterval colorectal cancerscreening colonoscopyadenomaReferencesЗлокачественные новообразования в России в 2020 году (заболеваемость и смертность) Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2021; илл., 252 с.Malignant neoplasms in Russia in 2020 (morbidity and mortality). Edited by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova – M.: P.A. Herzen Moscow State Medical Research Institute − Branch of the Federal State Budgetary Institution "NMIC of Radiology" of the Ministry of Health of Russia. 2021; fig., 252 p. (in Russ.).Baxter NN, et al. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011 Jan;140(1):65-72. doi: 10.1053/j.gastro.2010.09.006. Epub 2010 Sep 18.Baxter NN, et al. Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology. 2011 Jan;140(1):65-72. doi: 10.1053/j.gastro.2010.09.006. Epub 2010 Sep 18.Sanduleanu S, et al. Expert Working Group on ‘Right-sided lesions and interval cancers’. Colorectal Cancer Screening Committee, World Endoscopy Organization. Gut. 2015 Aug; 64(8): 1257-67. doi: 10.1136/gutjnl-2014-307992.Sanduleanu S, et al. Expert Working Group on ‘Right-sided lesions and interval cancers’. Colorectal Cancer Screening Committee, World Endoscopy Organization. Gut. 2015 Aug; 64(8): 1257-67. doi: 10.1136/gutjnl-2014-307992.Douglas AC, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014; 370: 1298–1306.Douglas AC, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014; 370: 1298–1306.Haseman JH, et al. Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc. 1997;45(06):451–455. doi: 10.1016/s0016-5107(97)70172-xHaseman JH, et al. Failure of colonoscopy to detect colorectal cancer: evaluation of 47 cases in 20 hospitals. Gastrointest Endosc. 1997;45(06):451–455. doi: 10.1016/s0016-5107(97)70172-xMasclee AM, Meijer GA, Sanduleanu S. Interval cancers after colonoscopy-insights and recommendations. Nat Rev Gastroenterol Hepatol. 2012;9(09):550–554. doi: 10.1038/nrgastro.2012.136.Masclee AM, Meijer GA, Sanduleanu S. Interval cancers after colonoscopy-insights and recommendations. Nat Rev Gastroenterol Hepatol. 2012;9(09):550–554. doi: 10.1038/nrgastro.2012.136.Murad MH, et al. Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol. 2014; 109(09):1375–1389. doi: 10.1038/ajg.2014.171Murad MH, et al. Prevalence, risk factors, and outcomes of interval colorectal cancers: a systematic review and meta-analysis. Am J Gastroenterol. 2014; 109(09):1375–1389. doi: 10.1038/ajg.2014.171Brenner H, et al. Does a negative screening colonoscopy ever need to be repeated? Gut. 2006; 55(08):1145–1150. doi: 10.1136/gut.2005.087130.Brenner H, et al. Does a negative screening colonoscopy ever need to be repeated? Gut. 2006; 55(08):1145–1150. doi: 10.1136/gut.2005.087130.Brenner H, et al. Interval cancers after negative colonoscopy: population-based case-control study. Gut. 2012;61(11):1576–1582. doi: 10.1136/gutjnl-2011-301531Brenner H, et al. Interval cancers after negative colonoscopy: population-based case-control study. Gut. 2012;61(11):1576–1582. doi: 10.1136/gutjnl-2011-301531Farrar WD, et al. Microsatellite instability in interval colon cancers. Gastroenterology. 2006; 131(06):1700–1705. doi: 10.1053/j.gastro.2006.10.022.Farrar WD, et al. Microsatellite instability in interval colon cancers. Gastroenterology. 2006; 131(06):1700–1705. doi: 10.1053/j.gastro.2006.10.022.Nishihara R, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013; 369(12):1095–1105. doi: 10.1056/NEJMoa1301969.Nishihara R, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013; 369(12):1095–1105. doi: 10.1056/NEJMoa1301969.Mustafa A Arain, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010; 105(05):1189–1195. doi: 10.1038/ajg.2009.699.Mustafa A Arain, et al. CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol. 2010; 105(05):1189–1195. doi: 10.1038/ajg.2009.699.Rex DK, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997; 112(1):24–8. doi: 10.1016/s0016-5085(97)70214-2.Rex DK, et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology. 1997; 112(1):24–8. doi: 10.1016/s0016-5085(97)70214-2.Singh H, et al. Rateand predictors of early/missed colorectal cancer safter colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 2010;105(12): 2588–2596. doi: 10.1038/ajg.2010.390.Singh H, et al. Rateand predictors of early/missed colorectal cancer safter colonoscopy in Manitoba: a population-based study. Am J Gastroenterol. 2010;105(12): 2588–2596. doi: 10.1038/ajg.2010.390.Millan MS, et al. Adenoma detection rate: the real indicator of quality in colonoscopy. Dis Colon Rectum. 2008; 51(8):1217–20. doi: 10.1007/s10350-008-9315-3.Millan MS, et al. Adenoma detection rate: the real indicator of quality in colonoscopy. Dis Colon Rectum. 2008; 51(8):1217–20. doi: 10.1007/s10350-008-9315-3.Kaminski MF, et al. Increased rate of adenoma detection associates with reduced risk of colorectal Cancer and death. Gastroenterology. 2017; 153(01):98–105. doi: 10.1053/j.gastro.2017.04.006.Kaminski MF, et al. Increased rate of adenoma detection associates with reduced risk of colorectal Cancer and death. Gastroenterology. 2017; 153(01):98–105. doi: 10.1053/j.gastro.2017.04.006.Hoff G, Holme O, Bretthauer M, et al. Cecum intubation rate as quality indicator in clinical versus screening colonoscopy. Endosc Int Open. 2017; 5(6): E489–95. doi: 10.1055/s-0043-106180Hoff G, Holme O, Bretthauer M, et al. Cecum intubation rate as quality indicator in clinical versus screening colonoscopy. Endosc Int Open. 2017; 5(6): E489–95. doi: 10.1055/s-0043-106180Hilsden RJ, et al. The association of colonoscopy quality indicators with the detection of screen-relevant lesions, adverse events, and post colonoscopy cancers in an asymptomatic Canadian colorectal cancer screening population. Gastrointest Endosc. 2015;82(05):887–894. doi: 10.1016/j.gie.2015.03.1914.Hilsden RJ, et al. The association of colonoscopy quality indicators with the detection of screen-relevant lesions, adverse events, and post colonoscopy cancers in an asymptomatic Canadian colorectal cancer screening population. Gastrointest Endosc. 2015;82(05):887–894. doi: 10.1016/j.gie.2015.03.1914.Anderson JC, Butterly LF. Colonoscopy: quality indicators. Clin Transl Gastroenterol. 2015 Feb 26;6(2):e77. doi: 10.1038/ctg.2015.5.Anderson JC, Butterly LF. Colonoscopy: quality indicators. Clin Transl Gastroenterol. 2015 Feb 26;6(2):e77. doi: 10.1038/ctg.2015.5.Gellad ZF, et al. Colonoscopy withdrawal time and risk of neoplasia at 5 years: results from VA Cooperative Studies Program 380. Am J Gastroenterol. 2010;105(08):1746–1752. doi: 10.1038/ajg.2010.107Gellad ZF, et al. Colonoscopy withdrawal time and risk of neoplasia at 5 years: results from VA Cooperative Studies Program 380. Am J Gastroenterol. 2010;105(08):1746–1752. doi: 10.1038/ajg.2010.107Van Heijningen EMB, et al. Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study. Gut. 2015;64(10): 1584–1592. doi: 10.1136/gutjnl-2013-306453Van Heijningen EMB, et al. Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study. Gut. 2015;64(10): 1584–1592. doi: 10.1136/gutjnl-2013-306453Tutticci NJ, Hewett DG, Leggett BA. Prevalence of serrated polyps: implications for significance as colorectal cancer precursors. Colorectal Cancer. 2013; 2:535–547 27 Nov 2013. https://doi.org/10.2217/crc.13.70Tutticci NJ, Hewett DG, Leggett BA. Prevalence of serrated polyps: implications for significance as colorectal cancer precursors. Colorectal Cancer. 2013; 2:535–547 27 Nov 2013. https://doi.org/10.2217/crc.13.70Anderson JC, et al. Higher Serrated Detection Rate Is Associated With Lower Risk for Post Colonoscopy Colorectal Cancer. Am J Gastroenterology. 114():p S137, October 2019. doi: 10.14309/01.ajg.0000590468.56713.85Anderson JC, et al. Higher Serrated Detection Rate Is Associated With Lower Risk for Post Colonoscopy Colorectal Cancer. Am J Gastroenterology. 114():p S137, October 2019. doi: 10.14309/01.ajg.0000590468.56713.85Петри А., Сэбин К. Наглядная медицинская статистика: учеб.пособие. (пер. с англ. Под ред. В.П.Леонова. 3-е изд., перераб. и доп.): ГЭОТАР-Медиа. 2015; 216 с.:ил.Petri A., Sabin K. Visual medical statistics: studies.the manual. (translated from English. Edited by V.P. Leonov. 3rd ed., reprint. and additional). GEOTAR-Media, 2015; 216 p.: ill. (in Russ.).Bond JH. Polyp guideline: diagnosis, treatment and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroent. 2000 Nov; 95(11):3053-63. doi: 10.1111/j.1572-0241Bond JH. Polyp guideline: diagnosis, treatment and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroent. 2000 Nov; 95(11):3053-63. doi: 10.1111/j.1572-0241Deenadayalu VP, Chadalawada V, Rex DK. 170 degrees wide-angle colonoscope: effect on efficiency and miss rates. Am J Gastroenterol. 2004 Nov; 99(11):2138-42.Deenadayalu VP, Chadalawada V, Rex DK. 170 degrees wide-angle colonoscope: effect on efficiency and miss rates. Am J Gastroenterol. 2004 Nov; 99(11):2138-42.Waldmann E, et al. Endoscopists with low adenoma detection rates benefit from high-definition endoscopy. Surg Endosc. 2015; 29:466–473. doi: 10.1007/s00464-014-3688-2.Waldmann E, et al. Endoscopists with low adenoma detection rates benefit from high-definition endoscopy. Surg Endosc. 2015; 29:466–473. doi: 10.1007/s00464-014-3688-2.Saikaly E., Saad MK. Postcolonoscopy Colorectal Cancer: An Overview and Future Directions. Journal of Coloproctology. 2021; 41(03): 301-307. doi: 10.1055/s-0041-1730014Saikaly E., Saad MK. Postcolonoscopy Colorectal Cancer: An Overview and Future Directions. Journal of Coloproctology. 2021; 41(03): 301-307. doi: 10.1055/s-0041-1730014Easy Fisher exact test calculator. https://www.socscistatistics.com/tests/fisher/default2.aspx //Easy Fisher exact test calculator. https://www.socscistatistics.com/tests/fisher/default2.aspx //

The authors declare that there are no conflicts of interest present.